“… Active | NF-κB pathway and macrophage activation | Not studied | [ 164 , 171 , 197 , 199 ] | GRA12 | TGGT1_288650 | IVN/PVM | Unknown | Inhibits IFN-γ mediated parasite killing | Active | Active | Not studied | - [ 172 ]
|
GRA14 | TGGT1_239740 | PV/PVM/IVN | Unknown | Activation of NF-κB pathway and recruitment of macrophages in type II parasites, potentially in other strains too | Active | Active | Not studied | [ 173 , 199 ] |
GRA15 | TGGT1_275470 | PVM | TRAF2/TRAF6 GBP1 | In type II parasites, activation of NF-κB pathway via TRAF2/6 interaction leading to IL-12 and IL-1B expression. Also linked to the inhibition of lysosomes fusion and GBP loading to the PVM | Truncated (and thus inactive) in some strains | Active | Active, but less than type II parasites | [ 174 , 198 , 199 , 205 , 206 ] |
GRA16 | TGGT1_208830 | Nucleus | PP2A-B55, HAUSP | Modulates the expression of host cell genes involved in the control of cell-cycle progression, p53 signaling, steroids and lipids metabolism | Less active? (no virulence phenotype for the KO) | Active | Not studied | [ |
…”